Evidence map›Paper›PMID 24170386›Full record

ArticleCirculation2013

High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.

Maarit Lehti, Elizabeth Donelan, William Abplanalp, Omar Al-Massadi, Kirk M Habegger, Jon Weber, Chandler Ress, Johannes Mansfeld, Sonal Somvanshi, Chitrang Trivedi and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 108 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Identification of Plasma Free Fatty Acid Carrier Proteins in Mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Exercise improves muscle mitochondrial dysfunction-associated lipid profile under circadian rhythm disturbance.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2024
    Article
  13. Review
  14. Observational
  15. Article
  16. New Player in an Old Field? Ecto-FArteriosclerosis, thrombosis, and vascular biology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 3 countries.

Maarit LehtiDiabetes Research Department (IDO and IDR), Helmholtz Zentrum München, German Research Center for Environmental Health, München/Neuherberg, Germany (M.L., M.K., T.O., C.S., S.C., P.T.P., S.M.H.); Metabolic Diseases Institute, Division of Endocrinology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH (M.L., E.D., W.A., O.A.-M., K.M.H., J.W., C.R., J.M., S.S., C.T., R.K., S.M.G., R.A.G.D.S., D.D., W.S.D., S.M.H.); LIKES Research Center for Sport and Health Sciences, Jyväskylä, Finland (M.L.); Energy Metabolism Laboratory ETH Zurich (Swiss Federal Institute of Technology), Zurich, Switzerland (J.M.); Department of Pharmacology and Toxicology, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India (C.T.); Univ Paris Diderot, Sorbonne Paris Cité, Unité de Biologie Fonctionnelle et Adaptative, Paris, France (S.L., J.C., S.M.); Centre National de la Recherche Scientifique, Paris, France (S.L., J.C., S.M.); and Medizinische Klinik, Ludwig Maximilians University, Munich, Germany (S.M.H.).
Elizabeth Donelan
William Abplanalp
Omar Al-Massadi
Kirk M Habegger
Jon Weber
Chandler Ress
Johannes Mansfeld
Sonal Somvanshi
Chitrang Trivedi
Michaela Keuper
Teja Ograjsek
Cynthia Striese
Sebastian Cucuruz
Paul T Pfluger
Radhakrishna Krishna
Scott M Gordon
R A Gangani D Silva
Serge Luquet
Julien Castel
Sarah Martinez
David D'Alessio
W Sean Davidson
Susanna M Hofmann
Centre de Gestion Scientifique · FRCentre National de la Recherche Scientifique · FRETH Zurich · CHCadila Healthcare (India) · IN

Funding

LIPID, LIPOPROTEIN, AND GLUCOSE METABOLISM COREU24DK059630 · NIDDK · UNIVERSITY OF CINCINNATI · PI TSO, PATRICK · 2001 to 2015
$12.9M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
Lipid profile, lipoprotein and apolipoprotein composition, and intestinal fat absorption efficiency in germ-free and conventional miceU2CDK059630 · NIDDK · UNIVERSITY OF CINCINNATI · PI LIU, MIN · 2016 to 2021
$4.9M
Ohio Interdisciplinary Women's Health Career TrainingK12HD051953 · NICHD · UNIVERSITY OF CINCINNATI · PI TSEVAT, JOEL · 2005 to 2014
$4.2M
NCATS NIH HHS UL1 TR000077NICHD NIH HHS 2K12HD051953-06NICHD NIH HHS K12 HD051953NIDDK NIH HHS U24 DK059630NIDDK NIH HHS U2C DK059630
6 · The paper itself

Abstract

backgroundAbnormal glucose metabolism is a central feature of disorders with increased rates of cardiovascular disease. Low levels of high-density lipoprotein (HDL) are a key predictor for cardiovascular disease. We used genetic mouse models with increased HDL levels (apolipoprotein A-I transgenic [apoA-I tg]) and reduced HDL levels (apoA-I-deficient [apoA-I ko]) to investigate whether HDL modulates mitochondrial bioenergetics in skeletal muscle. METHODS AND

resultsApoA-I ko mice exhibited fasting hyperglycemia and impaired glucose tolerance test compared with wild-type mice. Mitochondria isolated from gastrocnemius muscle of apoA-I ko mice displayed markedly blunted ATP synthesis. Endurance capacity during exercise exhaustion test was impaired in apoA-I ko mice. HDL directly enhanced glucose oxidation by increasing glycolysis and mitochondrial respiration rate in C2C12 muscle cells. ApoA-I tg mice exhibited lower fasting glucose levels, improved glucose tolerance test, increased lactate levels, reduced fat mass, associated with protection against age-induced decline of endurance capacity compared with wild-type mice. Circulating levels of fibroblast growth factor 21, a novel biomarker for mitochondrial respiratory chain deficiencies and inhibitor of white adipose lipolysis, were significantly reduced in apoA-I tg mice. Consistent with an increase in glucose utilization of skeletal muscle, genetically increased HDL and apoA-I levels in mice prevented high-fat diet-induced impairment of glucose homeostasis.

conclusionsIn view of impaired mitochondrial function and decreased HDL levels in type 2 diabetes mellitus, our findings indicate that HDL-raising therapies may preserve muscle mitochondrial function and address key aspects of type 2 diabetes mellitus beyond cardiovascular disease.

Indexed as

AnimalsApolipoprotein A-IBlood GlucoseCell RespirationCells, CulturedDiabetes Mellitus, Type 2Disease Models, AnimalFatty Acids, NonesterifiedFibroblast Growth FactorsGlucose IntoleranceHomeostasisHyperglycemiaLipoproteins, HDLMaleMiceMice, Inbred C57BLApolipoprotein A-IBlood GlucoseFatty Acids, Nonesterifiedfibroblast growth factor 21Fibroblast Growth FactorsLipoproteins, HDLcellular respirationcholesterol, HDLexerciseobesity

Identifiers

PMID24170386
PMCPMC3957345
OpenAlexW2112389427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.